Afatinib 30 mg Tablet Xovoltib

Trade Name: Xovoltib

Manufacturer: Boehringer Ingelheim

Presentation: Tablet

Strength: 30mg

What is the purpose of Afatinib 30 mg?

Afatinib 30 mg is a drug that is used to treat non-small cell lung cancer (NSCLC) that has progressed to other regions of the body and has certain types of faulty epidermal growth factor receptor (EGFR) genes in patients who have not had any treatments for cancer that has spread to other areas of the body.

When should you start taking afatinib?

Afatinib is taken once a day on an empty stomach. You should take them at least one hour before or after eating. Unless the adverse effects become too severe, you normally continue taking it for as long as it is still effective.

Is Afatinib 30 mg taken orally?

Afatinib is a tablet that is taken orally. Afatinib should be taken on an empty stomach at least 1 hour before or after a meal. Afatinib should be taken exactly as directed.

Is it safe to drink alcohol when taking Afatinib 30 mg?

Alcohol consumption (in tiny doses) appears to have no effect on the safety or effectiveness of afatinib. with afatinib treatment and for 2 weeks following the last dose. If you or your partner become pregnant, call your doctor straight away.

What is the rate of targeted therapy success?

The median overall survival (OS) following diagnosis of stage 5 disease was 6.8 years after a median follow-up of 47 months, demonstrating that 50% of patients were alive 6.8 years after diagnosis versus only 2% after 5 years.

Is insurance going to cover targeted therapy?

According to Vikas Gupta, a cancer consultant, targeted therapy costs Rs 10–20 lakh for six sessions. Those who have been diagnosed with cancer This is a one-of-a-kind policy for cancer survivors who seek medical coverage. In most cases, insurance companies refuse to cover such individuals.

Is Afatinib 30 mg a tyrosine kinase inhibitor (TKI)?

Afatinib is an irreversible pan-ErbB-TKI that works against wild-type, sensitizing, and T970M-mutant EGFR, ErbB2, and ErbB4 receptors, and marks a step forward from reversible first-generation EGFR-TKIs to future irreversible highly specific third-generation EGFR-TKIs.

Afatinib 30 mg has a number of adverse effects.

Mouth sores, pain/redness/swelling of the lips, dry/itchy skin, acne, nose bleeds, runny noses, nausea/vomiting, and loss of appetite are all possible side effects. Tell your doctor or pharmacist right away if any of these effects continue or worsen.

Click here if you’re seeking a different product or brand.